financetom
Business
financetom
/
Business
/
Bayer's Monsanto must pay $185 million after Washington court restores chemical leak verdict
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bayer's Monsanto must pay $185 million after Washington court restores chemical leak verdict
Oct 30, 2025 10:18 AM

Oct 30 (Reuters) - A U.S. court reinstated a $185

million verdict against Bayer's Monsanto over chemical

contamination at a Washington state school on Thursday.

The Washington state Supreme Court reversed a lower court's

ruling that vacated the verdict in a 2024 trial over claims

brought by three teachers at Sky Valley Education Center in

Monroe, Washington.

Bayer's Monsanto has faced a string of trials over claims

by teachers and others at Sky Valley Education Center in Monroe,

Washington, who say they were sickened by exposure to

polychlorinated biphenyls, or PCBs.

More than 200 students, employees and parents say they

developed cancer, thyroid conditions, neurological injuries and

other health problems from PCBs leaking from the school's light

fixtures. The chemicals were made by Monsanto, which Bayer

acquired in 2018.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Baidu Unveils AI-Powered Features in Mobile Ecosystem
Baidu Unveils AI-Powered Features in Mobile Ecosystem
May 31, 2024
08:00 AM EDT, 05/31/2024 (MT Newswires) -- Baidu ( BIDU ) said Friday it integrated large language models and ERNIE agents into its mobile products such as Baidu Search, ERNIE Bot App, Baidu App, and Baidu Wenku to make artificial intelligence more accessible. Baidu App users can now engage in multi-turn dialogue and use specialized agents for various tasks, while...
Gilead's Trodelvy extends lung cancer survival by just 1.3 months in trial
Gilead's Trodelvy extends lung cancer survival by just 1.3 months in trial
May 31, 2024
May 31 (Reuters) - Gilead Sciences' ( GILD ) Trodelvy improved survival by 1.3 months more than chemotherapy in previously treated patients with advanced lung cancer in a late-stage trial, a difference that was not statistically significant, the company said on Friday. Patients given Trodelvy lived for a median of 11.1 months, while those on chemotherapy lived for 9.8 months,...
JinkoSolar's Perovskite Tandem Solar Cell Sets Record
JinkoSolar's Perovskite Tandem Solar Cell Sets Record
May 31, 2024
08:00 AM EDT, 05/31/2024 (MT Newswires) -- JinkoSolar Holding Company ( JKS ) said Friday that it has achieved a significant breakthrough in the development of its N-type TOPCon-based perovskite tandem solar cell. The cell attained a conversion efficiency of 33.24%, well beyond JinkoSolar's ( JKS ) previous record of 32.33% for the same type of tandem cells, the company...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
May 31, 2024
May 31 (Reuters) - Pfizer ( PFE ) said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the strength of data presented on Friday showing most patients treated for a rare form of advanced lung cancer in a clinical trial were alive without the disease worsening after five years. Lorbrena, like Pfizer's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved